- Home
- EXAS vs KBR Comparison
EXAS vs KBR Comparison
Compare EXAS & KBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- KBR
- Stock Information
- Founded
- EXAS 1995
- KBR 1901
- Country
- EXAS United States
- KBR United States
- Employees
- EXAS N/A
- KBR N/A
- Industry
- EXAS Medical Specialities
- KBR Military/Government/Technical
- Sector
- EXAS Health Care
- KBR Industrials
- Exchange
- EXAS Nasdaq
- KBR Nasdaq
- Market Cap
- EXAS 10.7B
- KBR 6.3B
- IPO Year
- EXAS N/A
- KBR 2006
- Fundamental
- Price
- EXAS $53.17
- KBR $47.94
- Analyst Decision
- EXAS Strong Buy
- KBR Buy
- Analyst Count
- EXAS 20
- KBR 7
- Target Price
- EXAS $70.16
- KBR $68.33
- AVG Volume (30 Days)
- EXAS 2.8M
- KBR 1.4M
- Earning Date
- EXAS 07-30-2025
- KBR 07-23-2025
- Dividend Yield
- EXAS N/A
- KBR 1.38%
- EPS Growth
- EXAS N/A
- KBR N/A
- EPS
- EXAS N/A
- KBR 2.98
- Revenue
- EXAS $2,828,128,000.00
- KBR $7,979,000,000.00
- Revenue This Year
- EXAS $14.58
- KBR $14.27
- Revenue Next Year
- EXAS $12.75
- KBR $8.57
- P/E Ratio
- EXAS N/A
- KBR $16.10
- Revenue Growth
- EXAS 11.57
- KBR 12.84
- 52 Week Low
- EXAS $39.97
- KBR $43.89
- 52 Week High
- EXAS $72.83
- KBR $72.60
- Technical
- Relative Strength Index (RSI)
- EXAS 42.14
- KBR 33.76
- Support Level
- EXAS $50.09
- KBR $47.69
- Resistance Level
- EXAS $53.20
- KBR $49.47
- Average True Range (ATR)
- EXAS 1.78
- KBR 1.25
- MACD
- EXAS -0.53
- KBR -0.45
- Stochastic Oscillator
- EXAS 24.40
- KBR 13.72
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About KBR KBR Inc.
KBR, formerly Kellogg Brown & Root, is global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: government solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 34,000 people. The firm generated $7.7 billion in revenue in 2024.